Click and hold a term momentarily to select items without that term.
1 item
PKBSM6845SNYE
human beta cell line
EndoC-bH2 cells treated with extreme hyperglycemia from GSE212749
DMEM low glucose (1g/L), 2% Albumin from bovine serum fraction V, 50μM 2-mercaptoethanol, 10mM nicotinamide, 5.5 μg/mL transferrin, 6.7 ng/mL sodium selenite and Penicillin (100 units/mL)/Streptomycin (100 μg/mL)
EndoC-bH2
released
Supported by National Institutes of Health (NIH) grants U24 DK138515, U24 DK138512
Supplemental funds from the NIH Office of Data Science Strategies
Supplemental funds from the NIH Office of Data Science Strategies
